The most common type of CTCL is mycosis fungoides (MF). Mycosis fungoides was so named by a French dermatologist in the 1800s due to the mushroom like tumors that developed on the skin of a ...

By far the most common variant of CTCL is mycosis fungoides and its leukemic variant Sézary syndrome. Mycosis fungoides imposes a tremendous physical as well as psychological burden for patients ...

Mycosis fungoides is a type of skin cancer that affects the body's T cells, which are white blood cells intended to protect the body from infection. It is the most common form of cutaneous T-cell ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Azacitidine is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business ...

Marshall Davies, from Dawley, was diagnosed in April 2023 with folliculotropic mycosis fungoides, a rare and potentially aggressive type of cutaneous T-cell lymphoma. This has now progressed to ...

It is expressed by up to 50% of patients with mycosis fungoides and peripheral T-cell lymphoma (PTCL). It has a restricted expression on normal tissues. Lacutamab is granted European Medicines ...

Cutaneous T-cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that affects the skin. Here authors show that CDK9 degradation of retinoic acid receptor α is a vulnerability for CTCL and ...

The study primarily targets patients suffering from Sézary syndrome (SS) and mycosis fungoides (MF), two forms of CTCL that present with severe symptoms like intense itching and chronic skin ...

The MTD was determined to be duvelisib 25 mg BID plus 20 mg ruxolitinib BID. Baseline histologies included 14 (29%) TFH lymphomas, 13 (27%) PTCL-not otherwise specified, 7 (14%) mycosis fungoides (MF) ...